BCLIOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
BRAINSTORM CELL THERAPEUTICS INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.77−0.01 (-1.17%)
Close on Oct 19, 2026
- Market cap
- $8.50M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Brainstorm Cell Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 24, 2026 | Jul 30, 2026 | SEC EDGAR |
| Current report | 8-K | May 25, 2026 | May 28, 2026 | SEC EDGAR |
| Current report | 8-K | May 15, 2026 | May 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 31, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2026 | Mar 31, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2026 | Feb 27, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 9, 2026 | Feb 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 5, 2026 | Jan 9, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2025 | Nov 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 16, 2025 | Jul 17, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2025 | Jun 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 16, 2025 | Jun 16, 2025 | SEC EDGAR |
| Current report | 8-K | May 19, 2025 | May 19, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 25, 2025 | May 16, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Current report | 8-K | May 15, 2025 | May 15, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 20, 2025 | Apr 21, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 31, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2025 | Mar 31, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2025 | Mar 31, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2025 | Mar 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 21, 2025 | Jan 21, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 15, 2025 | Jan 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2024 | Oct 30, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 30, 2024 | Oct 1, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2024 | Oct 1, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 26, 2024 | Sep 26, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2024 | Sep 16, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 16, 2024 | Aug 16, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 14, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2024 | Aug 14, 2024 | SEC EDGAR |